Item | Interview 1 | Interview 2 | Interview 3 | Interview 4 |
---|---|---|---|---|
1-0 week before EUS | 0-1 week after EUS | 12 weeks ± 5 days after EUS | 48 weeks ± 5 days after EUS | |
Informed content | X | Â | Â | Â |
Inclusion criteria | X | Â | Â | Â |
Patient characteristics | X | Â | Â | Â |
Blood routine tests | X | X | Â | Â |
Coagulation routine tests1 | X | Â | Â | Â |
Blood biochemistry tests2 | X | X | Â | Â |
Blood tumor markers tests3 | X | Â | X | X |
Complications | Â | X | X | X |
Clinical signs4 | X | X | X | X |
Imaging examination | X | X | X | X |
Cytology examination | Â | X | Â | X |
Pathology examination | Â | X | Â | X |
Surgical-pathological examination | Â | X | X | X |
Therapies | Â | X | X | X |